CF PharmTech (02652) Announces Changes in Issued Shares and Share Repurchase

Bulletin Express

Feb 05

CF PharmTech (02652) reported that on 05 February 2026, a total of 11,000 H shares were repurchased on the Stock Exchange at prices ranging from HKD 34.7 to HKD 35.24, with an aggregate amount of HKD 385,280. These repurchased shares are held as treasury shares, increasing the total treasury shares to 212,000.

Following this transaction, the number of issued shares (excluding treasury shares) stands at 302,011,586, while the total number of issued shares remains at 302,223,586. The repurchase was carried out under a mandate resolved on 16 December 2025, which authorized up to 30,222,358 shares for repurchase. So far, 212,000 shares have been repurchased, representing approximately 0.0701% of the issued shares as of the resolution date.

According to the announcement, there is a 30-day period during which no new issuance or sale or transfer of treasury shares is permitted, lasting until 07 March 2026, unless approval is obtained from the Stock Exchange.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1130430922"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1130430922\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1130430922?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-05 18:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1130430922","market":"us","top_or_hot":-1,"title":"CF PharmTech (02652) Announces Changes in Issued Shares and Share Repurchase","media":"Bulletin Express","content":"<p>CF PharmTech (02652) reported that on 05 February 2026, a total of 11,000 H shares were repurchased on the Stock Exchange at prices ranging from HKD 34.7 to HKD 35.24, with an aggregate amount of HKD 385,280. These repurchased shares are held as treasury shares, increasing the total treasury shares to 212,000.</p>\n<p>Following this transaction, the number of issued shares (excluding treasury shares) stands at 302,011,586, while the total number of issued shares remains at 302,223,586. The repurchase was carried out under a mandate resolved on 16 December 2025, which authorized up to 30,222,358 shares for repurchase. So far, 212,000 shares have been repurchased, representing approximately 0.0701% of the issued shares as of the resolution date.</p>\n<p>According to the announcement, there is a 30-day period during which no new issuance or sale or transfer of treasury shares is permitted, lasting until 07 March 2026, unless approval is obtained from the Stock Exchange.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CF PharmTech (02652) Announces Changes in Issued Shares and Share Repurchase</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCF PharmTech (02652) Announces Changes in Issued Shares and Share Repurchase\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-05 18:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CF PharmTech (02652) reported that on 05 February 2026, a total of 11,000 H shares were repurchased on the Stock Exchange at prices ranging from HKD 34.7 to HKD 35.24, with an aggregate amount of HKD 385,280. These repurchased shares are held as treasury shares, increasing the total treasury shares to 212,000.</p>\n<p>Following this transaction, the number of issued shares (excluding treasury shares) stands at 302,011,586, while the total number of issued shares remains at 302,223,586. The repurchase was carried out under a mandate resolved on 16 December 2025, which authorized up to 30,222,358 shares for repurchase. So far, 212,000 shares have been repurchased, representing approximately 0.0701% of the issued shares as of the resolution date.</p>\n<p>According to the announcement, there is a 30-day period during which no new issuance or sale or transfer of treasury shares is permitted, lasting until 07 March 2026, unless approval is obtained from the Stock Exchange.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02652","symbol_name":"长风药业","start_time":0,"source_url":"","article_id":"1130430922","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1130430922","pubTimestamp":1770288288,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"CF PharmTech (02652) reported that on 05 February 2026, a total of 11,000 H shares were repurchased on the Stock Exchange at prices ranging from HKD 34.7 to HKD 35.24, with an aggregate amount of HKD...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02652":"长风药业"},"translate_title":"CF PharmTech(02652)公布已发行股份变动及股份购回","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02652":1},"content_text":"CF PharmTech (02652) reported that on 05 February 2026, a total of 11,000 H shares were repurchased on the Stock Exchange at prices ranging from HKD 34.7 to HKD 35.24, with an aggregate amount of HKD 385,280. These repurchased shares are held as treasury shares, increasing the total treasury shares to 212,000.\nFollowing this transaction, the number of issued shares (excluding treasury shares) stands at 302,011,586, while the total number of issued shares remains at 302,223,586. The repurchase was carried out under a mandate resolved on 16 December 2025, which authorized up to 30,222,358 shares for repurchase. So far, 212,000 shares have been repurchased, representing approximately 0.0701% of the issued shares as of the resolution date.\nAccording to the announcement, there is a 30-day period during which no new issuance or sale or transfer of treasury shares is permitted, lasting until 07 March 2026, unless approval is obtained from the Stock Exchange.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}